Cost-effectiveness of linezolid vs. vancomycin in nosocomial pneumonia due to suspected methicillin-resistant Staphylococcus aureus in France

被引：0
|
作者：
De Cock, E. [1 ]
Timsit, J. F. [2 ]
Carlet, J. [3 ]
Leroy, O. [4 ]
Wolff, M. [5 ]
Levrat, F. [6 ]
机构：
[1] United BioSource Corp, Barcelona, Spain
[2] Hop Albert Michallon, Grenoble, France
[3] Grp Hosp St Joseph, Paris, France
[4] Hop Guy, Tourcoing, France
[5] Hop Bichat Claude Bernard, F-75877 Paris 18, France
[6] Pfizer, Paris, France
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A439 / A439
页数：1
相关论文
共 50 条
  • [31] Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus
    Dipen A Patel
    Andrew F Shorr
    Jean Chastre
    Michael Niederman
    Andrew Simor
    Jennifer M Stephens
    Claudie Charbonneau
    Xin Gao
    Dilip Nathwani
    Critical Care, 18
  • [32] AN ECONOMIC MODEL TO COMPARE LINEZOLID AND VANCOMYCIN FOR THE TREATMENT OF CONFIRMED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS NOSOCOMIAL PNEUMONIA IN GERMANY
    Patel, D. A.
    Michel, A.
    Stephens, J. M.
    Weber, B.
    Gao, X.
    Charbonneau, C.
    VALUE IN HEALTH, 2013, 16 (07) : A354 - A354
  • [33] Linezolid vs. vancomycin in treatment of methicillin-resistant staphylococcus aureus infections: a meta-analysis
    Li, J.
    Zhao, Q. -H.
    Huang, K. -C.
    Li, Z. -O.
    Zhang, L. -Y.
    Qin, D. -Y.
    Pan, F.
    Huang, W. -X.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (17) : 3974 - 3979
  • [34] Cost-effectiveness of linezolid in methicillin-resistant Staphylococcus aureus skin and skin structure infections
    Bounthavong, Mark
    Hsu, Donald I.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (06) : 683 - 698
  • [35] Linezolid vs vancomycin in the treatment of methicillin-resistant Staphylococcus aureus infections in children
    Bruss, JB
    Edge-Padbury, B
    Naberhuis-Stehouwer, S
    Kaplan, SL
    PEDIATRIC RESEARCH, 2003, 53 (04) : 322A - 322A
  • [36] COST-EFFECTIVENESS ANALYSIS OF LINEZOLID VS VANCOMYCIN IN EMPIRIC TREATING MECHANIC VENTILATION- ASSOCIATED PNEUMONIA BY METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (VAP-MRSA) IN COLOMBIA
    Molina, F.
    Izquierdo, C.
    Caceres, H. A.
    Cortes, J.
    Soto, R.
    VALUE IN HEALTH, 2010, 13 (03) : A190 - A190
  • [37] Cost-effectiveness analysis of linezolid vs. vancomycin in treating methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections using a decision analytic model
    Bounthavong, M.
    Hsu, D. I.
    Okamoto, M. P.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (03) : 376 - 386
  • [38] Methicillin-resistant Staphylococcus aureus nosocomial pneumonia: role of linezolid in the People's Republic
    Lesher, Beth
    Gao, Xin
    Chen, Yixi
    Liu, Zhengyin
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2016, 8 : 63 - 72
  • [39] Pneumonia Caused by Community-Acquired Methicillin-Resistant Staphylococcus aureus: Vancomycin or Linezolid?
    Tian Ye
    Huang Xu
    Wu Li-Juan
    Yi Li
    Li Min
    Gu Si-Chao
    Guo Dong-Jie
    Zhan Qing-Yuan
    中华医学杂志英文版, 2018, 131 (16)
  • [40] Pneumonia Caused by Community-Acquired Methicillin-Resistant Staphylococcus aureus: Vancomycin or Linezolid?
    Tian, Ye
    Huang, Xu
    Wu, U-Juan
    Yi, Li
    Li, Min
    Gu, Si-Chao
    Guo, Dong-Jie
    Zhan, Qing-Yuan
    CHINESE MEDICAL JOURNAL, 2018, 131 (16) : 2002 - 2004
12345